Tag: RSV
-
Ross River Virus Cases Quadruple in South Australia in 2025: What You Need to Know
Understanding Ross River Virus and Its Spread Ross River Virus (RRV) is a mosquito-borne infection that affects people across Australia, with symptoms resembling a severe flu: fever, joint pain, fatigue, and rashes. While most cases are not life-threatening, the illness can be debilitating for weeks or months. In South Australia, health authorities monitor RRV activity…
-
Low RSV Maternal Vaccination Uptake in Japan: New Survey Findings
Overview: Why maternal RSV vaccination matters Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections in young children. Vaccinating pregnant women can transfer protective antibodies to the fetus, helping newborns fight RSV in their first months of life. This protective strategy—administered during pregnancy—has the potential to reduce hospitalizations and severe disease…
-
Low Uptake of Maternal RSV Vaccination in Japan: What the Survey Reveals
Overview: Why Maternal RSV Vaccination Matters RSV, or respiratory syncytial virus, is a leading cause of acute lower respiratory infections in young children. Administering RSV vaccines to pregnant women enables antibodies to transfer through the placenta, offering newborns protection during the first months of life. This strategy has the potential to reduce hospitalizations and severe…
-
RSV vaccines show clear benefit as officials push new restrictions
Rising evidence supports RSV vaccines amid policy debate As U.S. health policymakers consider tightening restrictions on vaccines, including those designed to prevent respiratory syncytial virus (RSV), a growing body of research underscores a straightforward public health benefit: RSV vaccines substantially reduce hospitalizations, especially among the most vulnerable populations. The tension between expanding access to vaccines…
-
Evidence Mounts on RSV Vaccines as U.S. Push for Restrictions Intensifies
RSV Vaccines Demonstrate Clear Benefit Amid Policy Shifts As U.S. officials advance new restrictions on vaccines, including those designed to prevent respiratory syncytial virus (RSV), a growing body of evidence underscores a straightforward public-health message: RSV vaccines can substantially reduce hospitalizations. The debate between policy moves and clinical data centers on how best to balance…
-
RSV More Severe Than Influenza in Hospitalized Patients With Malignancy: New Study Highlights Risk
RSV Outpaces Influenza in Severity Among Hospitalized Patients With Malignancy Emerging evidence from a recent study published in Open Forum Infectious Diseases indicates that respiratory syncytial virus (RSV) infections tend to be more severe than influenza in people with malignancy who are hospitalized. The findings add an important dimension to how clinicians assess risk, allocate…
-
RSV Outpaces Flu in Severity for Cancer Patients Hospitalized with Respiratory Infections
Overview: RSV poses a greater threat than influenza for patients with cancer Recent findings published in Open Forum Infectious Diseases reveal that respiratory syncytial virus (RSV) leads to more severe disease than influenza among patients with malignancy who are hospitalized for respiratory viral infections (RVI). The study sheds light on a vulnerable population where cancer-related…
-
RSV More Severe Than Influenza in Hospitalized Patients With Malignancy: A Closer Look at RVI Impact
Understanding the New Findings A recent study highlighted in Open Forum Infectious Diseases indicates that respiratory syncytial virus (RSV) causes more severe illness than influenza among patients with malignancies who are hospitalized for respiratory viral infections (RVI). The research underscores how immune-compromised individuals, such as those undergoing cancer treatment, face heightened risks from RSV compared…
-
RSVpreF maternal vaccination lowers infant hospitalizations
Real-world evidence confirms the protective effect of RSVpreF during pregnancy New real-world data reinforce the importance of maternal vaccination against respiratory syncytial virus (RSV) using the pre-fusion F (RSVpreF) protein. In recent analyses, infants whose mothers received the RSVpreF vaccine during pregnancy showed a substantial reduction in hospitalizations due to RSV infection during the first…
-
Maternal RSVpreF Vaccination Lowers Infant Hospitalization Risk
Overview: Maternal RSVpreF vaccination and infant protection New real-world evidence is reinforcing the protective effect of maternal vaccination against respiratory syncytial virus (RSV) in early infancy. Data emerging from observational studies suggest that vaccinating pregnant people with the RSV pre-fusion F (RSVpreF) vaccine is associated with a substantial reduction in hospitalizations among young infants, particularly…